Brief: Hansa Biopharma Announces Planned Departure Of CFO Donato Spota
27/11/2023 06:03
Nov 27 (Reuters) - Hansa Biopharma AB HNSA.ST :
* HANSA BIOPHARMA ANNOUNCES PLANNED DEPARTURE OF CHIEF
FINANCIAL
OFFICER DONATO SPOTA
* SPOTA LAST DAY WILL BE 28 FEBRUARY 2024
* SEARCH IS UNDERWAY FOR NEW CFO
Source text for Eikon: ID:nWkr9lV5CH
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS